Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: CK1441RCZ8

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Insulin-like growth factor I receptor antagonist PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Ovarian Neoplasms 2 D010051 ClinicalTrials
Sarcoma, Ewing 2 D012512 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Hemangiosarcoma 2 D006394 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 1 D002289 ClinicalTrials
Rhabdomyosarcoma 1 D012208 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Small Cell Lung Carcinoma 1 D055752 ClinicalTrials
Pancreatic Neoplasms 1 D010190 ClinicalTrials
Sarcoma 0 D012509 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 905703-97-1
ChEMBL CHEMBL1743024
FDA SRS CK1441RCZ8